NASDAQ:CAI | Cash Flow Statement | Caris Life Sciences, Inc.

Complete source-backed cash-flow history.

Available history
2023-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$637,000.00$6.5M
2026-03-31-$510,000.00$5.07M$32.88M$10.34M-$10.34M$0.00$824,000.00
2025-12-31$81.96M$4.29M$44.78M$5.09M-$5.09M$91,000.00$3.4M
2025-09-30$24.33M$4.9M
2025-06-30-$71.79M$6.4M
2025-03-31-$102.58M$7.05M-$31.34M$2.69M-$2.69M$22,000.00$1.29M
2024-12-31-$36.95M$9.07M-$38.92M$2.29M-$2.29M$0.00$226,000.00
2024-09-30-$67.73M$10.5M
2024-06-30-$66.19M$11.6M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$68.09M$22.62M$83.16M$16.26M-$16.26M$113,000.00$664.99M
2024-12-31-$281.89M$48.91M-$245.2M$8.44M$52.93M$0.00$200.29M
2023-12-31-$341.42M$49M-$276.1M$22.32M$214.77M$0.00$10.13M